Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124483302 | 12448330 | 2 | F | 2011 | 20160808 | 20160608 | 20160815 | EXP | US-DSJP-DSU-2016-110423 | DAIICHI | 0.00 | Y | 0.00000 | 20160815 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124483302 | 12448330 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 20 MG, UNK | U | 21286 | 20 | MG | TABLET | |||||||
| 124483302 | 12448330 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | UNK | U | 21286 | TABLET | |||||||||
| 124483302 | 12448330 | 3 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 20MG/12.5 MG, UNK | U | 0 | 1 | DF | FILM-COATED TABLET | |||||||
| 124483302 | 12448330 | 4 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/12.5 MG, UNK | U | 0 | 1 | DF | FILM-COATED TABLET | |||||||
| 124483302 | 12448330 | 5 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/25 MG, UNK | U | 0 | 1 | DF | FILM-COATED TABLET | |||||||
| 124483302 | 12448330 | 6 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | UNK | 0 | |||||||||||
| 124483302 | 12448330 | 7 | C | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 124483302 | 12448330 | 8 | C | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | UNK | 0 | |||||||||||
| 124483302 | 12448330 | 9 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124483302 | 12448330 | 1 | Hypertension |
| 124483302 | 12448330 | 3 | Hypertension |
| 124483302 | 12448330 | 6 | Product used for unknown indication |
| 124483302 | 12448330 | 7 | Product used for unknown indication |
| 124483302 | 12448330 | 8 | Product used for unknown indication |
| 124483302 | 12448330 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124483302 | 12448330 | OT |
| 124483302 | 12448330 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124483302 | 12448330 | Acute kidney injury | |
| 124483302 | 12448330 | Constipation | |
| 124483302 | 12448330 | Diverticulitis | |
| 124483302 | 12448330 | Malabsorption | |
| 124483302 | 12448330 | Umbilical hernia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124483302 | 12448330 | 1 | 2007 | 2008 | 0 | |
| 124483302 | 12448330 | 2 | 2009 | 0 | ||
| 124483302 | 12448330 | 3 | 2009 | 0 | ||
| 124483302 | 12448330 | 4 | 2009 | 0 | ||
| 124483302 | 12448330 | 5 | 2009 | 0 |